ClinicalTrials.Veeva

Menu

Comparison of Patient-reported Pain After Initial Archwire Placement (Archwires)

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Enrolling

Conditions

Pain, Orofacial
Orthodontic Discomfort

Treatments

Device: Device: 0.016" Ormco 27oC NiTi orthodontic archwire
Device: 3M Unitek 0.016 orthodontic archwire
Device: Device: 0.016" Ormco 35oC NiTi orthodontic archwire

Study type

Interventional

Funder types

Other

Identifiers

NCT03906422
18-1737

Details and patient eligibility

About

Three different types of 'archwires' can be used in Orthodontic treatment, wire choice is decided by treating Orthodontist based on professional preference since research shows that all types are equally effective.

It is possible that one type of wire engenders more patient discomfort. This study will compare the discomfort levels engendered by the three wire types to determine if there is one that induces the least amount.

Full description

Orthodontic treatment with fixed appliances has the potential to induce pain in patients. At the beginning of treatment, the orthodontist must determine which initial orthodontic archwire to insert. Among the more popular choices for initial leveling and aligning of the dental arches are small-sized, round-diameter nickel-titanium archwires. Various types of nickel-titanium (NiTi) archwires exist including stabilized martensitic wires (ie classic Nitinol), active austenitic wires (superelastic NiTi) and active martensitic wires (thermoelastic NiTi). The efficacy of these wire types has been heavily researched with no significant differences in the alignment timing of the dentition (treatment time to reach the final archwire). Pain differences from these wires has been inconclusive from conflicting past studies. It is of critical importance to determine whether one or more of these archwires leads to more discomfort for the patient than the others.

Enrollment

126 estimated patients

Sex

All

Ages

12+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Healthy, with no significant systemic diseases or complications or special needs
  2. Requiring a minimum of 1 dental arch (first molar to first molar) labial fixed orthodontic appliance banded/bonded in 1 appointment
  3. All banded/bonded teeth can be ligated to initial archwire (no severely displaced or blocked out teeth).
  4. Any planned dental extractions that is part of the orthodontic treatment plan must be carried out at least 3 weeks prior to or after initial orthodontic appliance bonding.
  5. Age 12 years or older

Exclusion criteria

  1. Currently taking or recently taken sulfonamides, monoamine oxidase inhibitors, tricyclic antidepressants, or phenothiazines
  2. Currently taking physician-prescribed medical marijuana for the management of pain or recreational marijuana during the trial period
  3. Metal-type (Nickel) allergies
  4. Less than 12 years old
  5. Same day use of analgesics prior to bonding
  6. Treatment requiring dental extractions prior to or immediately after bonding of fixed appliance

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

126 participants in 3 patient groups

A: 0.016" Nitinol
Experimental group
Description:
0.016" Nitinol (3M Unitek, Monrovia, CA) archwire to be tied to the fixed orthodontic brackets at the initial bonding appointment.
Treatment:
Device: 3M Unitek 0.016 orthodontic archwire
B: 0.016" Ormco 27oC NiTi
Experimental group
Description:
0.016" Ormco 27oC NiTi (Ormco, Glendora, CA) archwire to be tied to the fixed orthodontic brackets at the initial bonding appointment.
Treatment:
Device: Device: 0.016" Ormco 27oC NiTi orthodontic archwire
C: 0.016" Ormco 35oC NiTi
Experimental group
Description:
0.016" Ormco 35oC NiTi (Ormco, Glendora, CA) archwire to be tied to the fixed orthodontic brackets at the initial bonding appointment.
Treatment:
Device: Device: 0.016" Ormco 35oC NiTi orthodontic archwire

Trial contacts and locations

1

Loading...

Central trial contact

Clifton M Carey, PhD; Craig Shellhart, DDS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems